# Glaucoma Ophthalmology * **Definition:** A specialized branch of ophthalmology focused on the diagnosis, treatment, and management of glaucoma, a group of eye conditions that damage the optic nerve, often associated with increased intraocular pressure, leading to vision loss if untreated. * **Taxonomy:** Specialties / Glaucoma Ophthalmology ## News * Selected news on the topic of **Glaucoma Ophthalmology**, for healthcare technology leaders * 1.3K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 4/24/2025 | [**A golden era for personalized medicine is approaching, but are we ready?**](https://medicalxpress.com/news/2025-04-golden-era-personalized-medicine-approaching.html) | [[MedicalXpress]] | | 2/25/2025 | [**A Glimpse Into the Future of Eye Care at SECO 2025**](https://www.ajmc.com/view/a-glimpse-into-the-future-of-eye-care-at-seco-2025) | [[AJMC]] | | 12/13/2024 | [**Optometry Software Market In North America , 100f Growth to Originate from North America, Technavio**](https://www.prnewswire.com/news-releases/optometry-software-market-in-north-america--100-of-growth-to-originate-from-north-america-technavio-302330766.html) | [[PR Newswire]] | | 12/13/2024 | [**Optometry Software Market In North America , 100f Growth to Originate from ... - Yahoo Finance**](https://finance.yahoo.com/news/optometry-software-market-north-america-071400175.html) | [[Yahoo Finance]] | | 12/11/2024 | [**Do AI Diagnostics have a role in telemedicine? What does this mean for healthcare equity?**](https://www.healthtechmagazines.com/do-ai-diagnostics-have-a-role-in-telemedicine-what-does-this-mean-for-healthcare-equity/) | [[Health Tech Magazines]] | | 12/2/2024 | [**St. Louis-based eye care group names IT chief**](https://www.bizjournals.com/stlouis/news/2024/12/02/eyecare-partners-names-chief-information-officer.html) | [[The Business Journals]] | | 11/22/2024 | [**North America's Optometry Software Market to Grow by USD 576.62 Million (2024-2028 ...**](https://www.prnewswire.com/news-releases/north-americas-optometry-software-market-to-grow-by-usd-576-62-million-2024-2028-driven-by-rising-ophthalmic-disease-cases-ai-redefining-market-landscape---technavio-302313504.html) | [[PR Newswire]] | | 11/20/2024 | [**Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market With ...**](https://finance.yahoo.com/news/avant-technologies-ainnova-advancing-proprietary-130000965.html) | [[Yahoo Finance]] | | 11/20/2024 | [**Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market ... - Morningstar**](https://www.morningstar.com/news/globe-newswire/9276540/avant-technologies-and-ainnova-advancing-proprietary-retinal-camera-to-market-with-vision-ai-software) | [[Morningstar]] | | 11/19/2024 | [**The 8 next big technologies in health for 2024 - Fast Company**](https://www.fastcompany.com/91224656/health-next-big-things-in-tech-2024) | [[Fast Company]] | | 11/19/2024 | [**Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market With Vision AI Software**](https://markets.businessinsider.com/news/stocks/avant-technologies-and-ainnova-advancing-proprietary-retinal-camera-to-market-with-vision-ai-software-1034041795) | [[Business Insider Markets]] | | 11/4/2024 | [**Ring Therapeutics Announces New Strategic Partnerships with A*STAR and SERI to ... - Morningstar**](https://www.morningstar.com/news/globe-newswire/9267140/ring-therapeutics-announces-new-strategic-partnerships-with-astar-and-seri-to-establish-gene-therapy-rd-efforts-in-singapore-a-growing-global-biotech-hub) | [[Morningstar]] | | 10/22/2024 | [**It's official: Michelle Tarver named director of the FDA's devices center**](https://www.fiercebiotech.com/medtech/its-official-michelle-tarver-named-director-fdas-devices-center) | [[FierceBiotech]] | | 10/18/2024 | [**12 threats stifling ASC success**](https://www.beckersasc.com/leadership/12-threats-stifling-asc-success.html) | [[Beckers ASC Review]] | | 10/9/2024 | [**Verana Health Introduces Qdata Explorer in Advance of 2024 American Academy of Ophthalmology Annual Meeting**](https://www.globenewswire.com/news-release/2024/10/09/2960574/0/en/Verana-Health-Introduces-Qdata-Explorer-in-Advance-of-2024-American-Academy-of-Ophthalmology-Annual-Meeting.html) | [[Globe Newswire]] | | 10/9/2024 | [**Verana Health Introduces Qdata Explorer in Advance of 2024 American Academy of ... - Morningstar**](https://www.morningstar.com/news/globe-newswire/9253301/verana-health-introduces-qdata-explorer-in-advance-of-2024-american-academy-of-ophthalmology-annual-meeting) | [[Morningstar]] | | 10/9/2024 | [**Verana Health Introduces Qdata Explorer in Advance of 2024 American Academy of ...**](https://finance.yahoo.com/news/verana-health-introduces-qdata-explorer-130000987.html) | [[Yahoo Finance]] | | 10/8/2024 | [**Verana Health Introduces Qdata Explorer in Advance of 2024 American Academy of Ophthalmology Annual Meeting**](https://markets.businessinsider.com/news/stocks/verana-health-introduces-qdata-explorer-in-advance-of-2024-american-academy-of-ophthalmology-annual-meeting-1033831657) | [[Business Insider Markets]] | | 10/7/2024 | [**AI is Redefining the Disposable Hospital Supplies Market, Projected to Grow by USD 24.5 Billion from 2024 to 2028 Amid Rising Hospitalizations**](https://www.prnewswire.com/news-releases/ai-is-redefining-the-disposable-hospital-supplies-market-projected-to-grow-by-usd-24-5-billion-from-2024-to-2028-amid-rising-hospitalizations-302267735.html) | [[PR Newswire]] | | 10/4/2024 | [**AI revolutionizes ophthalmology with oculomics for cardiovascular risk assessment**](https://www.news-medical.net/news/20241004/AI-revolutionizes-ophthalmology-with-oculomics-for-cardiovascular-risk-assessment.aspx) | [[News Medical Net]] | | 9/6/2024 | [**JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System**](http://www.businesswire.com/news/home/20240906392607/en/JuneBrain-Receives-MDIC-Advanced-Manufacturing-Clearing-House-Award-Selects-Compliance-Group-to-Implement-Siemens-Polarion-Design-Quality-System/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 8/21/2024 | [**Thirona Retina BV acquired by Revenio Group subsidiary iCare**](https://www.med-technews.com/news/medtech-business-merger-acquisition-finance-and-investment-news/thirona-retina-bv-acquired-by-revenio-group-subsidiary-icare/) | [[Med-Tech Innovation News]] | | 8/21/2024 | [**South Korea Adeno-Associated Virus Gene Therapy Market By Applications - - LinkedIn**](https://www.linkedin.com/pulse/south-korea-adeno-associated-virus-gene-366xf) | [[Linkedin]] | | 8/8/2024 | [**Chutes & Ladders—Biogen CMO Maha Radhakrishnan joins Sofinnova**](https://www.fiercebiotech.com/biotech/chutes-ladders-biogen-cmo-maha-radhakrishnan-joins-sofinnova) | [[FierceBiotech]] | | 7/24/2024 | [**MedWorld Advisors announces the formation of the MedTech Laser Group**](https://www.med-technews.com/news/medtech-business-merger-acquisition-finance-and-investment-news/medworld-advisors-announces-the-formation-of-the-medtech-laser-group/) | [[Med-Tech Innovation News]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **SightMD**: An ophthalmology group enhancing its team with specialists in glaucoma and comprehensive eye care. - **John A. Moran Eye Center**: A leading ophthalmology facility collaborating on glaucoma research. - **Orbis International**: An organization conducting training projects to improve eye care capabilities, including glaucoma treatment. - **Ike Ahmed, MD**: A renowned glaucoma surgeon leading research on aqueous outflow dynamics. - **Sight Sciences, Inc.**: A company focused on innovative eye care solutions, particularly in surgical glaucoma treatments. - **Ocuvex Therapeutics**: Acquired Visiox Pharmaceuticals, focusing on developing therapies for glaucoma and other eye disorders. - **Ian Pitha, MD, PhD**: A distinguished scientist contributing to glaucoma treatment research. - **ViaLase, Inc.**: A company focused on innovative laser procedures for glaucoma treatment. - **Bausch + Lomb**: A global eye health company that acquired Elios Vision to enhance its glaucoma treatment portfolio. - **Prem Subramanian, MD, PhD**: An ophthalmology professor conducting research on eye changes in astronauts during space missions, utilizing advanced ocular equipment. - **Neos™**: A technology used by ophthalmologists for objective measurements in neuro-ophthalmic conditions. - **Eyenuk**: A digital healthcare company utilizing AI for the detection and prevention of blinding eye diseases, including glaucoma. - **MediPrint Ophthalmics**: Developed a 3D printed drug-eluting contact lens for sustained delivery of glaucoma medication. - **Skye Bioscience**: Developing cannabinoid-based therapies for glaucoma, though facing challenges in efficacy. - **Fiona McDonnell, PhD**: A distinguished scientist involved in glaucoma research. - **Negev Labs**: Engaged in developing non-hallucinogenic neuroplastogens for treating various disorders, including glaucoma. - **Ocumension Therapeutics**: A Chinese ophthalmic pharmaceutical company expanding its portfolio through strategic acquisitions. - **Eyefinity**: A leading provider of optometry software solutions, expanding offerings to meet increasing demand. - **EyeCare Partners**: A national network of ophthalmologists and optometrists providing comprehensive eye care services. - **TOPVISION Eye Specialist Berhad**: A company specializing in comprehensive eye care treatments, including glaucoma management, which recently transferred its listing to the ACE Market of Bursa Malaysia. ### Partnerships and Collaborations - **ViaLase and John A. Moran Eye Center**: Research partnership to explore the dynamics of aqueous outflow in glaucoma treatment. - **Negev Labs and ASRI**: Collaboration to develop safer compounds for treating eye diseases, including glaucoma. - **UCL and Moorfields Eye Hospital**: Developed an AI system to enhance patient recruitment for clinical trials in Geographic Atrophy. - **Orbis International**: Conducting ophthalmic training projects in Bangladesh to improve eye care capabilities. - **EyeCare Partners and UMass Memorial Health**: Integration of AI-based diagnostic solutions to enhance diabetic eye care. - **Orbis International and Alcon Foundation**: Collaboration to enhance eye care training and capabilities in Mongolia. - **USC Roski Eye Institute and other organizations**: Collaborating on the THEIA project to advance eye transplantation techniques. - **Ocumension and Alcon**: Ocumension acquired commercialization rights for Alcon's dry eye treatments in China, enhancing its product portfolio. - **Verana Health and American Academy of Ophthalmology**: Collaboration to curate and analyze data from the IRIS Registry, the largest clinical data registry in medicine. - **EssilorLuxottica and Heidelberg Engineering**: Acquisition aimed at enhancing growth in the med-tech sector and improving patient care. - **Avirmax and ARVO**: Avirmax collaborates with ARVO to present advancements in ocular gene therapy, showcasing their research and innovations at conferences. - **AEYE Health and UMass Memorial Health**: Collaborated to integrate AEYE-DS into the EMR system, improving diabetic retinopathy screening adherence. - **Avant Technologies and Ainnova Tech**: Collaborating to advance low-cost retinal cameras and AI software for early disease detection. - **TOPVISION and Bursa Malaysia**: Transfer of listing to enhance market confidence and growth potential in eye care services. - **Eximia and Tidewater Clinical Research**: Eximia integrated Tidewater into its clinical trial network to enhance research capabilities in ophthalmology. - **Thirona and iCare Finland Oy**: Partnering to enhance patient outcomes and drive innovation in eye care through AI-driven technology. - **ViaLase and Global Surgical Service**: Distribution partnerships to support the rollout of the ViaLase Laser in European markets. - **MedWorld Advisors with A.R.C Laser and neoLaser**: This acquisition aims to expand the medical laser technology sector while maintaining the independent operations of both companies. - **Compliance Group and JuneBrain**: A partnership to implement a digital data-centric Design Quality System for medical device startups, enhancing regulatory compliance. ### Innovations, Trends, and Initiatives - **AI in Ophthalmology**: Growing trend of integrating AI for rapid diagnosis and management of eye diseases, including glaucoma. - **Large-scale Data Extraction**: Research from The University of Western Australia analyzing visual field tests to improve glaucoma management. - **Optical Coherence Tomography (OCT)**: Leading imaging technology in ophthalmology, crucial for diagnosing conditions like glaucoma. - **AI-Powered Diagnostic Tools**: Utilization of AI in ophthalmology to improve diagnostic accuracy and treatment plans, particularly in glaucoma management. - **iPerfusion Technology**: Advanced technology used to study aqueous humor drainage, crucial for understanding glaucoma treatment effectiveness. - **Remote Monitoring Systems**: Beilinson Hospital's integration of remote monitoring for tracking intraocular pressure in glaucoma patients. - **ViaLase Laser Procedure**: A novel, incision-free approach to glaucoma treatment aimed at lowering intraocular pressure. - **FLigHT (Femtosecond Laser, Image-Guided, High-Precision Trabeculotomy)**: A new non-invasive glaucoma treatment method showing promise in lowering intraocular pressure and improving long-term outcomes. - **ELIOS Procedure**: A minimally invasive glaucoma surgery developed by Elios Vision, enhancing treatment options for glaucoma patients. - **Direct Selective Laser Trabeculoplasty (DSLT)**: A minimally invasive laser treatment for glaucoma acquired by Alcon, aiming for FDA clearance. - **Universal Design for Healthcare**: Focus on addressing visual disabilities, including glaucoma, through inclusive design principles. - **Teleophthalmology**: This trend is enhancing access to eye care, particularly in underserved areas. - **Ophthalmic Artificial Intelligence**: Establishment of centers focused on AI research to improve early diagnosis of eye diseases. - **3D Printed Drug Delivery**: MediPrint's innovative approach to glaucoma treatment through sustained release of medication via contact lenses. - **Cloud-Based Optometry Software**: Growing trend in the optometry software market, enhancing operational efficiency and remote patient consultations. - **Telehealth Services**: Expansion of remote patient monitoring and telehealth capabilities in managing eye health. - **Smart Contact Lenses**: Innovative technology being used in research to monitor eye pressure and dimensions in astronauts, contributing to understanding ocular health in microgravity. ### Challenges and Concerns - **Complexity of Eye Diseases**: The multifaceted nature of glaucoma and other eye diseases necessitates continuous innovation and education in treatment approaches. - **Irreversible Blindness**: Glaucoma is a significant cause of irreversible blindness, necessitating effective treatment solutions. - **Access to Care**: Despite advancements, there are ongoing challenges in ensuring equitable access to glaucoma treatments and technologies. - **Patient Access**: Ensuring equitable access to advanced therapies for glaucoma patients remains a significant challenge. - **Patient Compliance**: Ensuring patients adhere to treatment regimens remains a challenge in managing glaucoma. - **Demographic Disparities**: Significant differences in glaucoma prevalence among racial groups, highlighting the need for targeted public health strategies. - **Risks of Cosmetic Eye Procedures**: Concerns over the safety of cosmetic procedures like keratopigmentation, which may lead to serious complications including glaucoma. - **Efficacy of Cannabinoid Treatments**: Despite potential benefits, cannabinoid-based treatments for glaucoma face skepticism regarding their effectiveness. - **Aging Population**: An increasing number of elderly individuals may lead to a higher prevalence of eye diseases, necessitating improved healthcare delivery. - **Access to Eye Care**: Despite advancements, there are ongoing concerns about accessibility and cost of eye care technologies. - **Market Saturation**: Potential for moderate growth rates in the optometry software market due to saturation in the U.S. eyecare infrastructure. - **Healthcare Access Disparities**: There are significant disparities in access to eye care, which require collaborative efforts among healthcare providers and advocacy groups. - **Regulatory Restrictions**: Concerns regarding the integration of AI in healthcare, particularly in ophthalmology, affecting reimbursement models and clinician workload. - **Reimbursement Issues**: Concerns regarding declining reimbursement rates for procedures like cataract surgeries may impact the viability of Ambulatory Surgery Centers (ASCs). - **Healthcare Spending**: Rising costs and the need for innovative funding solutions to support ongoing research and development. - **Regulatory Approvals**: New technologies and treatments, such as the ELIOS system, face hurdles in obtaining necessary regulatory approvals. - **Regulatory Pressures**: Increased regulatory requirements pose operational challenges for ASCs, particularly in states with Certificate-of-Need laws. - **Regulatory Hurdles**: Navigating the regulatory landscape for gene therapies can be complex, impacting the speed of bringing innovations to market. ## Related Topics [[Ophthalmology]]; [[Neuro-Ophthalmology]]